3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
1645
Carcinoma, Renal Cell
505
Urinary Bladder Neoplasms
462
Carcinoma, Transitional Cell
236
Breast Neoplasms
228
Kidney Neoplasms
218
Neoplasms
194
Carcinoma, Non-Small-Cell Lung
173
Colorectal Neoplasms
172
Ovarian Neoplasms
163
Melanoma
163
Neoplasm Metastasis
144
Lung Neoplasms
128
Non-Muscle Invasive Bladder Neoplasms
107
Pancreatic Neoplasms
103
Stomach Neoplasms
101
Uterine Cervical Neoplasms
93
Squamous Cell Carcinoma of Head and Neck
86
Endometrial Neoplasms
84
Carcinoma, Hepatocellular
77
Sarcoma
76
Esophageal Neoplasms
72
Head and Neck Neoplasms
70
Triple Negative Breast Neoplasms
67
Adenocarcinoma
67
Colonic Neoplasms
53
Testicular Neoplasms
52
Disease
47
Wilms Tumor
46
Urologic Neoplasms
46
Interventions
durvalumab
1
Gemcitabine
1
Cisplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gallbladder Cancer Unresectable
×
Genitourinary
×
1 year
×
Clear all
NCT06591650
2026-05-14
GCND
Fudan University
Phase 2
Recruiting
33 enrolled